BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10940510)

  • 61. The serum assay of tumour markers in the prognostic evaluation, treatment monitoring and follow-up of patients with cervical cancer: a review of the literature.
    Gadducci A; Tana R; Cosio S; Genazzani AR
    Crit Rev Oncol Hematol; 2008 Apr; 66(1):10-20. PubMed ID: 17964182
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Pretreatment and treatment factors associated with improved outcome in squamous cell carcinoma of the uterine cervix: a final report of the 1973 and 1978 patterns of care studies.
    Lanciano RM; Won M; Coia LR; Hanks GE
    Int J Radiat Oncol Biol Phys; 1991 Apr; 20(4):667-76. PubMed ID: 2004942
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R; Zhang H; Zou L; Qu Y
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Determination of the SCC antigen in the serum of patients with cervical cancer].
    Crombach G; Würz H; Bolte A
    Geburtshilfe Frauenheilkd; 1987 Jul; 47(7):439-45. PubMed ID: 3623046
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Enzyme-linked PNA lectin-binding assay of serum T-antigen in patients with SCC of the uterine cervix.
    Reddi AL; Sankaranarayanan K; Arulraj HS; Devaraj N; Devaraj H
    Cancer Lett; 2000 Feb; 149(1-2):207-11. PubMed ID: 10737726
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Suppression of carbonyl reductase expression enhances malignant behaviour in uterine cervical squamous cell carcinoma: carbonyl reductase predicts prognosis and lymph node metastasis.
    Murakami A; Fukushima C; Yoshidomi K; Sueoka K; Nawata S; Yokoyama Y; Tsuchida S; Ismail E; Al-Mulla F; Sugino N
    Cancer Lett; 2011 Dec; 311(1):77-84. PubMed ID: 21824723
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Comparison of clinical outcomes of squamous cell carcinoma, adenocarcinoma, and adenosquamous carcinoma of the uterine cervix after definitive radiotherapy: a population-based analysis.
    Zhou J; Wu SG; Sun JY; Li FY; Lin HX; Chen QH; He ZY
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):115-122. PubMed ID: 27646608
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Experiences with the squamous cell carcinoma antigen, a new tumor marker for cancer of the uterine cervix].
    Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
    Geburtshilfe Frauenheilkd; 1989 Jul; 49(7):625-9. PubMed ID: 2777050
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Differential clinical characteristics, treatment response and prognosis of locally advanced adenocarcinoma/adenosquamous carcinoma and squamous cell carcinoma of cervix treated with definitive radiotherapy.
    Chen JL; Huang CY; Huang YS; Chen RJ; Wang CW; Chen YH; Cheng JC; Cheng AL; Kuo SH
    Acta Obstet Gynecol Scand; 2014 Jul; 93(7):661-8. PubMed ID: 24666257
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of TPA versus SCC-Ag, CEA and neopterin in carcinoma of the uterine cervix.
    Volgger B; Aspisirengil C; Genser-Krimbacher E; Ciresa-Koenig A; Daxenbichler G; Fuchs D; Windbichler G; Marth C
    Cancer Lett; 2008 Apr; 262(2):183-9. PubMed ID: 18226853
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [DNA flow cytometry: perspective prognostic parameters in carcinoma of the uterine cervix].
    Anton M; Nenutil R; Kopecný J; Rejthar A; Zaloudík J; Hausner P; Ptácková B
    Cesk Gynekol; 1992 Apr; 57(2):49-55. PubMed ID: 1628337
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [The importance of the SCC antigen in the diagnosis and follow-up of cervix carcinoma. A cooperative study of the Gynecologic Tumor Marker Group (GTMG)].
    Crombach G; Würz H; Herrmann F; Kreienberg R; Möbus V; Schmidt-Rhode P; Sturm G; Caffier H; Kaesemann H
    Dtsch Med Wochenschr; 1989 May; 114(18):700-5. PubMed ID: 2714197
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Expression and clinical significance of phosphoglycerate dehydrogenase and squamous cell carcinoma antigen in cervical cancer.
    Jing Z; Heng W; Aiping D; Yafei Q; Shulan Z
    Int J Gynecol Cancer; 2013 Oct; 23(8):1465-9. PubMed ID: 24247658
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Measurement of serum squamous cell carcinoma antigen levels as a predictor of radiation response in patients with carcinoma of the uterine cervix.
    Ohno T; Nakayama Y; Nakamoto S; Kato S; Imai R; Nonaka T; Ishikawa H; Harashima K; Suzuki Y
    Cancer; 2003 Jun; 97(12):3114-20. PubMed ID: 12784349
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Combination of squamous cell carcinoma-antigen, carcinoembryonic antigen, and carbohydrate antigen 19-9 predicts positive pelvic lymph nodes and parametrial involvement in early stage squamous cell carcinoma of the uterine cervix.
    Ikeda S; Yoshimura K; Onda T; Kasamatsu T; Kato T; Ishikawa M; Sasajima Y; Tsuda H
    J Obstet Gynaecol Res; 2012 Oct; 38(10):1260-5. PubMed ID: 22563932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Influence of serum VEGF levels on therapeutic outcome and diagnosis/prognostic value in patients with cervical cancer.
    Du K; Gong HY; Gong ZM
    Asian Pac J Cancer Prev; 2014; 15(20):8793-6. PubMed ID: 25374209
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The configuration of biomolecular markers in cancer of the uterine cervix. Personalized therapy. Monitoring and prognosis.
    Prunoiu VM; Marincaş MA; Cirimbei C; Ionescu S; Zurac S; Radu M; Nicolaescu R; Brătucu E; Straja ND;
    Chirurgia (Bucur); 2015; 110(2):144-50. PubMed ID: 26011836
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic Significance of Pre-treatment Serum C-Reactive Protein Level in Patients with Adenocarcinoma of the Uterine Cervix.
    Bodner-Adler B; Kimberger O; Schneidinger C; Kölbl H; Bodner K
    Anticancer Res; 2016 Sep; 36(9):4691-6. PubMed ID: 27630314
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Synchronous occurrence of carcinoma of the uterine cervix and of the breast.
    Sharma DN; Chander S; Awasthy BS; Rath GK
    Eur J Surg Oncol; 1999 Oct; 25(5):547-8. PubMed ID: 10527607
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Various prognostic aspects in squamous epithelial cervix carcinoma of clinical stage I-III].
    Elling D
    Zentralbl Gynakol; 1978; 100(3):143-50. PubMed ID: 654647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.